Helmholtz Zentrum München
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 1K
- Market Cap
- -
Clinical Trials
4
Active:1
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity
Not Applicable
Active, not recruiting
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2021-02-24
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Helmholtz Zentrum München
- Target Recruit Count
- 1149
- Registration Number
- NCT04769037
- Locations
- 🇧🇪
University Hospitals Leuven Faculty of Medicine, Catholic University of Leuven, Leuven, Belgium
🇩🇪Universitätsklinikum Carl Gustav Carus Technische Universität Dresden, Dresden, Germany
🇩🇪AUF DER BULT, Kinder- und Jugendkrankenhaus, Hannover, Germany
Fr1da Early Diagnosis and Care of Type 1 Diabetes
Recruiting
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2019-07-31
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Helmholtz Zentrum München
- Target Recruit Count
- 285000
- Registration Number
- NCT04039945
- Locations
- 🇩🇪
Institut für Diabetesforschung, Helmholtz Zentrum München, Munich, Germany
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
Recruiting
- Conditions
- Identification of Infants at Risk for Type 1 Diabetes
- First Posted Date
- 2017-10-20
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Helmholtz Zentrum München
- Target Recruit Count
- 1000000
- Registration Number
- NCT03316261
- Locations
- 🇩🇪
Institut für Diabetesforschung, Helmholtz Zentrum München, Munich, Germany
News
No news found